CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP21A2 | Cytochrome P450, family 21, subfamily A, polypeptide 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
TH | Tyrosine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
NOV | Nephroblastoma overexpressed | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | Predicted intracellular proteins
| | | | | Group enriched |
ARHGAP36 | Rho GTPase activating protein 36 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PNMT | Phenylethanolamine N-methyltransferase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CHGB | Chromogranin B (secretogranin 1) | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
INA | Internexin neuronal intermediate filament protein, alpha | Predicted intracellular proteins
| | | | | Group enriched |
STAR | Steroidogenic acute regulatory protein | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
RAB3C | RAB3C, member RAS oncogene family | Predicted intracellular proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | Predicted intracellular proteins
| | | | | Group enriched |
MGARP | Mitochondria-localized glutamic acid-rich protein | Predicted membrane proteins
| | | | | Tissue enriched |
RTL1 | Retrotransposon-like 1 | Predicted membrane proteins
| | | | | Group enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
SYT4 | Synaptotagmin IV | Predicted intracellular proteins
| | | | | Group enriched |
NR0B1 | Nuclear receptor subfamily 0, group B, member 1 | Cancer-related genes Disease related genes Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
RALYL | RALY RNA binding protein-like | Predicted intracellular proteins
| | | | | Group enriched |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
FAM135B | Family with sequence similarity 135, member B | Predicted intracellular proteins
| | | | | Group enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NDRG4 | NDRG family member 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SCARB1 | Scavenger receptor class B, member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
PEG10 | Paternally expressed 10 | Predicted intracellular proteins
| | | | | Group enriched |
SORBS2 | Sorbin and SH3 domain containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CADPS | Ca++-dependent secretion activator | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL22A1 | Collagen, type XXII, alpha 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DFNB31 | Deafness, autosomal recessive 31 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNAJC12 | DnaJ (Hsp40) homolog, subfamily C, member 12 | Predicted intracellular proteins
| | | | | Tissue enhanced |